Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 775-780

  Cai, Xiao Yan ^a   Wang, Jia Xing ^a   Yi, Yong ^a   He, Hong Wei ^a   Ni, Xiao Chun ^a   Zhou, Jian ^a   Cheng, Yun Feng ^a   Jin, Jian Jun ^a   Fan, Jia ^a   Qiu, Shuang Jian ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Prognosis; Recurrence; T cells

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CANCER STAGING; CHINA; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; LIVER; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS; SURVIVAL RATE; T LYMPHOCYTE; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; CHINA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SURVIVAL RATE; T-LYMPHOCYTES;

EID: 84894663638     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.775     Document Type: Article

References (31)

1. Bonneville M, O'Brien RL, Born WK (2010) Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol, 10, 467-78.
2. Born WK, Reardon CL, O'Brien RL (2006) The function of gammadelta T cells in innate immunity. Curr Opin Immunol, 18, 31-8.
3. Braza MS, Caraux A, Rousset T et al (2010) gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes. J Immunol, 184, 134-40.
4. Braza MS, Klein B, Fiol G et al (2011) gammadelta T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody. Haematologica, 96, 400-7.
5. Caccamo N, Meraviglia S, Ferlazzo V et al (2005) Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vgamma9Vdelta2 naive, memory and effector T cell subsets. Eur J Immunol, 35, 1764-72.
6. Cai XY, Gao Q, Qiu SJ et al (2006) Dendritic cell infiltration and prognosis of human hepatocellular carcinoma. J Cancer Res Clin Oncol, 132, 293-301.
7. Dunn GP, Bruce AT, Ikeda H et al (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol, 3, 991-8.
8. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76.
9. Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science, 313, 1960-4.
10. Gao B, Jeong WI, Tian Z (2008) Liver: An organ with predominant innate immunity. Hepatology, 47, 729-36.
11. Gao Q, Qiu SJ, Fan J et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol, 25, 2586-93.
12. Gao Q, Wang XY, Qiu SJ et al (2009) Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin Cancer Res, 15, 971-9.
13. Gao Q, Zhou J, Wang XY et al (2012) Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma. Ann Surg Oncol, 19, 455-66.
14. Guo L, Kuroda N, Toi M et al (2001) Increased expression of platelet-derived endothelial cell growth factor in human hepatocellular carcinomas correlated with high Edmondson grades and portal vein tumor thrombosis. Oncol Rep, 8, 871-6.
15. Ikai I, Arii S, Kojiro M et al (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer, 101, 796-802.
16. Ikeda H, Old LJ, Schreiber RD (2002) The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev, 13, 95-109.
17. Inman BA, Frigola X, Harris KJ et al (2008) Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma. J Immunol, 180, 3578-84.
18. Ju MJ, Qiu SJ, Gao Q et al (2009) Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma. Cancer Sci, 100, 1267-74.
19. Kew MC (2012) Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment. World J Hepatol, 4, 99-104.
20. Kowalczyk D, Skorupski W, Kwias Z et al (1996) Activated gamma/delta T lymphocytes infiltrating renal cell carcinoma. Immunol Lett, 53, 15-8.
21. Kuang DM, Peng C, Zhao Q et al (2010) Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology, 51, 154-64.
22. Kuang DM, Zhao Q, Peng C et al (2009) Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med, 206, 1327-37.
23. Li YW, Qiu SJ, Fan J et al (2011) Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J Hepatol, 54, 497-505.
24. Liao R, Wu H, Yi Y et al (2013) Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma. J Exp Clin Cancer Res, 32, 22.
25. Llovet JM, Di Bisceglie AM, Bruix J et al (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst, 100, 698-711.
26. Norris S, Collins C, Doherty DG et al (1998) Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol, 28, 84-90.
27. Wu H, Chen P, Liao R et al (2012) Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. J Gastroenterol Hepatol, 27, 1312-9.
28. Wu X, Zhang JY, Huang A et al (2013) Decreased Vdelta2 gammadelta T cells associated with liver damage by regulation of Th17 response in patients with chronic hepatitis B. J Infect Dis, 208, 1294-304.
29. Yi Y, He HW, Wang JX et al (2013a) The functional impairment of HCC-infiltrating gammadelta T cells, partially mediated by regulatory T cells in a TGFbeta-and IL-10-dependent manner. J Hepatol, 58, 977-83.
30. Yi Y, Wu H, Gao Q et al (2013b) Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC. Ann Surg Oncol, 20, 267-76.
31. Zhou H, Huang H, Shi J et al (2010) Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection. Gut, 59, 1699-708.